TOLL BIOTECH
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets. It was established in April 2020 and is initiated by the team of Professor Yin Hang, School of Pharmacy, Tsinghua University.
TOLL BIOTECH
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2020-04-01
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Total Funding:
10 M CNY
More informations about "Toll Biotech"
北京拓领博泰生物科技有限公司-北京拓领博泰生物科技有限公司
版权所有 1999 - 2021 toll-biotech.com 网站名称： 北京拓领博泰生物科技有限公司 备案号： 京ICP备2021017537号 京ICP备2021017537号See details»
Toll Biotech - Crunchbase Company Profile & Funding
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets. New. Resources. ...See details»
Toll Biotech 2025 Company Profile: Valuation, Funding …
Toll Biotech General Information Description. Developer of biotechnology focusing on the research and development of new drugs for autoimmune diseases. The company has a number of small molecule patents that regulate …See details»
Toll Biotech Co.Ltd.(Beijing) - Drug pipelines, Patents ... - Patsnap
Explore Toll Biotech Co.Ltd.(Beijing) with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, Disease Domain:Immune System Diseases, Technology Platform:Small …See details»
Toll Biotech - Funding, Financials, Valuation & Investors
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets. ... Experience the new Crunchbase, powered by …See details»
Toll Biotech - VentureRadar
Toll Biotech is a Chinese startup founded in 2020 to develop small molecule drugs, with new targets and new mechanisms of action, for autoimmune diseases. The company was founded …See details»
企业简介 - toll-biotech.com
版权所有 1999 - 2021 toll-biotech.com 网站名称： 北京拓领博泰生物科技有限公司 备案号： 京ICP备2021017537号 京ICP备2021017537号See details»
Toll Biotech Co.Ltd. (Beijing) (北京拓领博泰生物科技有限公司) - 药 …
了解Toll Biotech Co.Ltd.(Beijing) (北京拓领博泰生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验, 30篇新闻，疾病领域:免疫系统疾病，技术平台:小分子化药， …See details»
TollB-002 - Drug Targets, Indications, Patents - Synapse
2 days ago Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
北京拓领博泰生物科技有限公司 - 爱企查
简介： 1、基本情况 北京拓领博泰生物科技有限公司是一家科技型中小企业(2023)、小微企业，该公司成立于2020年04月09日，位于北京市昌平区生命科学园医科路9号院4号楼1层101，目前 …See details»
Toll Biotech Co., Ltd. (北京拓领博泰生物科技有限公司) - 药物管线_ …
了解Toll Biotech Co., Ltd. (北京拓领博泰生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的。See details»
Angel Round - Toll Biotech - 2021-03-18 - Crunchbase
Organization Name . Toll Biotech . Announced Date Mar 18, 2021; Funding Type ...See details»
TollB-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
Mar 15, 2025 A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and …See details»
Top 21 Leading Pharmaceutical Contract Manufacturing …
CordenPharma is a full-service Contract Development & Manufacturing Organization (CDMO) that produces APIs, Excipients, Drug Products, and Packaging Services. They translate complex …See details»
拓领博泰高萌博士获评 - toll-biotech.com
客服邮箱： lili@toll-biotech.com 版权所有 1999 - 2021 toll-biotech.com 网站名称： 北京拓领博泰生物科技有限公司 备案号： 京ICP备2021017537号See details»
Top biotech associations around the world
Biotech associations play a crucial role in advancing the industry by connecting biotech companies, pharmaceutical firms, academic institutions, research organizations, policymakers, …See details»
拓领博泰1.1类新药TollB-001片正式获FDA ... - toll-biotech.com
客服邮箱： lili@toll-biotech.com 版权所有 1999 - 2021 toll-biotech.com 网站名称： 北京拓领博泰生物科技有限公司 备案号： 京ICP备2021017537号See details»
Longevity Biotech Market Report, [2025-2033]
Mar 3, 2025 global longevity biotech market size expected to rise from USD 27.15 billion in 2024 and is anticipated to reach USD 46.61 billion by 2033, a CAGR of 6.5%. ... within the …See details»
The most innovative biotech companies of 2025 - Fast Company
4 days ago In December, IO Biotech entered a loan agreement of up to €57.5 million from the European Investment Bank, the long-term lending institution of the European Union, to fund …See details»
Establishing Canada’s first large-scale bioinnovation centre
2 days ago A one-of-a-kind facility in Canada, the Neptune BioInnovation Centre (NBC) will encourage biotechnology advancements in areas such as smart materials, bioplastics, …See details»